These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 31270617)
1. Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children. Hyun HS; Kim JH; Cho MH; Park E; Ha IS; Cheong HI; Kang HG Pediatr Nephrol; 2019 Nov; 34(11):2399-2407. PubMed ID: 31270617 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. Tinelli M; Cataldo MA; Mantengoli E; Cadeddu C; Cunietti E; Luzzaro F; Rossolini GM; Tacconelli E J Antimicrob Chemother; 2012 Dec; 67(12):2982-7. PubMed ID: 22865381 [TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre. Jacmel L; Timsit S; Ferroni A; Auregan C; Angoulvant F; Chéron G Acta Paediatr; 2017 Jan; 106(1):142-147. PubMed ID: 27542840 [TBL] [Abstract][Full Text] [Related]
5. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria. Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alnajjar AA Pediatr Int; 2023; 65(1):e15620. PubMed ID: 37735838 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland. O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687 [TBL] [Abstract][Full Text] [Related]
7. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital. Osthoff M; McGuinness SL; Wagen AZ; Eisen DP Int J Infect Dis; 2015 May; 34():79-83. PubMed ID: 25769526 [TBL] [Abstract][Full Text] [Related]
8. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common. Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972 [TBL] [Abstract][Full Text] [Related]
10. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children. Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784 [TBL] [Abstract][Full Text] [Related]
12. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017). Cantón R; Loza E; Aznar J; Castillo FJ; Cercenado E; Fraile-Ribot PA; González-Romo F; López-Hontangas JL; Rodríguez-Lozano J; Suárez-Barrenechea AI; Tubau F; Díaz-Regañón J; López-Mendoza D; Rev Esp Quimioter; 2019 Apr; 32(2):145-155. PubMed ID: 30761824 [TBL] [Abstract][Full Text] [Related]
13. Emergence of Extended-Spectrum β-Lactamase-Producing Pathogens in Community-Acquired Urinary Tract Infections Among Infants at a Pediatric Emergency Department. Tamas V; Shah S; Hollenbach KA; Kanegaye JT Pediatr Emerg Care; 2022 Mar; 38(3):e1053-e1057. PubMed ID: 35226630 [TBL] [Abstract][Full Text] [Related]
14. Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched casecontrol study. Dotis J; Printza N; Marneri A; Gidaris D; Papachristou F Turk J Pediatr; 2013; 55(6):571-4. PubMed ID: 24577973 [TBL] [Abstract][Full Text] [Related]
15. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. Han SB; Lee SC; Lee SY; Jeong DC; Kang JH BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143 [TBL] [Abstract][Full Text] [Related]